Angle PLC
LSE:AGL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Angle PLC
Accounts Payable
Angle PLC
Accounts Payable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Angle PLC
LSE:AGL
|
Accounts Payable
£2.2m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Smith & Nephew PLC
LSE:SN
|
Accounts Payable
$1.2B
|
CAGR 3-Years
2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
LivaNova PLC
NASDAQ:LIVN
|
Accounts Payable
$97.2m
|
CAGR 3-Years
9%
|
CAGR 5-Years
6%
|
CAGR 10-Years
27%
|
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Accounts Payable
£5.3m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-4%
|
|
|
Creo Medical Group PLC
LSE:CREO
|
Accounts Payable
£4.8m
|
CAGR 3-Years
11%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
|
Inspiration Healthcare Group PLC
LSE:IHC
|
Accounts Payable
£4.3m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
10%
|
|
Angle PLC
Glance View
ANGLE Plc operates as a holding company, through its subsidiaries engages in providing products in cancer diagnostics and foetal health. The company is headquartered in Guildford, Surrey and currently employs 102 full-time employees. The company went IPO on 2004-03-17. The Company’s lead product is the Parsortix cell separation system, which captures very rare cells from the blood. This includes circulating tumor cells (CTCs) in cancer patient blood even when there is less than one CTC in one billion healthy cells. The Parsortix cell separation system uses a microfluidic technology in the form of a one-time use cassette to capture and then harvest circulating tumor cells (CTCs) from blood. The cassette captures CTCs based on their less deformable nature and larger size compared to other blood components. The Company’s translational research includes ovarian cancer, breast cancer, prostate cancer and small cell lung cancer.
See Also
What is Angle PLC's Accounts Payable?
Accounts Payable
2.2m
GBP
Based on the financial report for Jun 30, 2025, Angle PLC's Accounts Payable amounts to 2.2m GBP.
What is Angle PLC's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
1%
Over the last year, the Accounts Payable growth was -36%. The average annual Accounts Payable growth rates for Angle PLC have been -18% over the past three years , 1% over the past five years .
